Talin variant P229S compromises integrin activation and associates with multifaceted clinical symptoms.
Saved in:
| Title: | Talin variant P229S compromises integrin activation and associates with multifaceted clinical symptoms. |
|---|---|
| Authors: | Azizi L; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Varela L; School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK., Turkki P; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Fimlab Laboratories, Tampere, Finland., Mykuliak VV; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Korpela S; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Ihalainen TO; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Church J; Clinical Immunology and Allergy, Children's Hospital Los Angeles, Los Angeles, CA, USA., Hytönen VP; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.; Fimlab Laboratories, Tampere, Finland., Goult BT; School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK. |
| Source: | Human molecular genetics [Hum Mol Genet] 2022 Dec 16; Vol. 31 (24), pp. 4159-4172. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: IRL Press at Oxford University Press Country of Publication: England NLM ID: 9208958 Publication Model: Print Cited Medium: Internet ISSN: 1460-2083 (Electronic) Linking ISSN: 09646906 NLM ISO Abbreviation: Hum Mol Genet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2083 |
|---|---|
| DOI: | 10.1093/hmg/ddac163 |
